Global Oncology Nutrition Market Is Expanding Rapidly With Nestle Health Science Launching a Clear Nutritional Drink ‘Boost Soothe’, Specifically Designed For Cancer Patients

 

Oncology Nutrition Market

Oncology nutrition describes the combination of diet and natural remedies for patients diagnosed with cancer. The reason this term has been chosen is because of the large emphasis hospitals have placed on nutrition over the past few decades. Nutrition is simply the best way to ensure that our bodies are as healthy as possible at all times. Unfortunately, our diets have changed very little over the years, if at all. This has led to a situation in which many individuals suffering from various diseases including cancer are getting sicker because they are not receiving the proper nutrients that they need on a daily basis

Increasing prevalence of chronic disease cancer, diabetes, and CVD, and lifestyle disorders is expected to drive growth of the global cell-based assay market during the forecast period. According to the World Health Organization (WHO), in 2018, around 9.6 million deaths were attributed to cancer, of which 2.09 million cases were lung cancer. . According to the World Cancer Research Fund (WCRF), in 2018, around 2 million new cases of breast cancer were recorded across the globe. According to the U.S. Breast Cancer Statistics, 1 in 8 U.S. women, around 12%, is expected to develop invasive breast cancer over the course of their lifetime. Oncology nutritionists specialize in helping patients develop a diet plan for good nutrition. The main objective is to improve the overall health of the cancer patient, help reduce the risk of cancer by keeping them healthier during treatment, and combat side-effects. Hence, such factors are expected to drive growth of the global oncology nutrition market. Furthermore, the advent of novel oncology nutrition products is expected to propel the global oncology nutrition market growth in the near future.

High cost associated with premium nutrition products for oncology is expected to restrain growth of the global oncology nutrition market. Among regions, North America is expected to witness significant growth in the global oncology nutrition market. This is owing to a high prevalence of cancer and the availability of robust healthcare infrastructure across the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to increasing investment in healthcare infrastructure in the region.

Key companies involved in the global oncology nutrition market are Abbott Laboratories, Mead Johnson & Company, LLC, Nestle S.A., Victus, Inc., Fresenius Kabi AG, Global Health Products, Inc., B. Braun Melsungen AG, Meiji Holdings Company, Ltd., Hormel Foods Corporation, and Danone S.A.

For instance, in September 2019, Nestle Health Science, a division of Nestle S.A., launched BOOST Soothe clear nutritional drink, specially designed for cancer patients.

Comments

Post a Comment

Popular posts from this blog

The Emergence of COVID-19 to Augment Growth of the Outsourced Drug Discovery Market

Image
  With billions of dollars in research and development costs, pharmaceutical companies around the world are always looking for new ways to address their production processes in a cost-effective manner. One way to achieve this is through outsourcing drug discovery and development services. This type of service refers to the collaboration between small and large biotech and biotechnology companies to conduct research and development activities aimed at finding better solutions to the company's core chemical concerns. Outsourcing of these drug discovery services has enabled established pharmaceutical and biotechnology companies to focus on the development of new products that can bring about significant therapeutic change and provide tangible advantages to the company's shareholders. Contract research organizations manage almost all aspects of drug discovery. Market Dynamics I ncreasing demand for outsourcing analytical testing and clinical trial services, growing R&D ex...
Read more

Otoscope Market Is Gaining Major Traction with Industry Leader Otonexus Medical Technologies Introducing Ultrasound Sensor, Which Aids Middle-Ear Infection Diagnosis

Image
  An otoscope or auricular ear picker is a simple health care tool that is used to inspect the outer ear. Many health care professionals utilize otoscopes to examine ear infections during routine check-ups and to also screen for serious ear disorders. An otoscope possibly provides a more detailed view of the external ear canal and/or ear drum or eardrum. Otoscope or also referred to as auriscope is mainly used to look into eyes. The demand for these medical devices has been on a rise in the recent past. This is typically due to the fact that there is a high burden of ENT-related diseases across the globe. As per the World Health Organization (WHO), by 2050, around 2.5 billion people are estimated to have some degree of hearing loss worldwide. Similarly, there is a heavy burden of sinusitis cases. As per the Sinusitis & Allergy Wellness Center, around 30 million adults in the U.S. are impacted with sinusitis annually. Such a high prevalence of ENT disorders has accelerated the d...
Read more

The Number of Cancer Survivors Is Projected To Increase to 22.2 Million By 2030 Fostering Oncology Drug Pipeline Analysis Market

Image
  North America is estimated to dominate the global oncology drug pipeline analysis market in the near future and this is attributed to the high prevalence of cancer and increasing launch of various novel drugs with improved efficacy. According to the National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors in the United States. The number of cancer survivors is projected to increase to 22.2 million by 2030. The oncology field is experiencing significant growth and this is attributed to the increasing development of various novel therapies for the treatment of cancer. For instance, in February 2021, Rhizen Pharmaceuticals AG, a clinical-stage, oncology-focused biopharma company, with a 50% stake owned by Alembic Pharmaceuticals and the rest by its Indian CEO Swaroop Vakkalanka, has announced that its the novel, next-generation PI3K-delta inhibitor Umbralisib (Ukoniq) has secured U.S. FDA accelerated approval for the treatment of blood c...
Read more